Literature DB >> 19740385

Clone clusters in autoreactive CD4 T-cell lines from probable multiple sclerosis patients form disease-characteristic signatures.

Mathilda Mandel1, Anat Achiron, Tamir Tuller, Tilda Barliya, Gideon Rechavi, Ninette Amariglio, Ron Loewenthal, Gad Lavie.   

Abstract

We developed a method for selectively propagating disease-related autoreactive T-cell lines (auTCLs) based on their increased resistance to apoptosis. The generated auTCLs homogeneously co-express CD45RO and CD49a, adhere strongly to extracellular matrix proteins and express high interleukin-17 (IL-17) messenger RNA levels, resembling a T-cell subset proposed to transmigrate into tissues and induce systemic and local inflammation in rheumatoid arthritis. The combinations of T-cell oligoclones that comprise probable multiple sclerosis (pMS) disease-related lines use a unique portfolio of T-cell receptor beta-chain variable allele (BV genes) combinations forming 'disease-specific cluster patterns'. The auTCL derived from different patients and from different myelin epitopes display striking similarities in BV gene allele clusters and are derived primarily from a disease-prone hotspot residing in the BV gene locus between Vbeta6 and Vbeta9. Conversely, healthy subject TCLs use different BV gene allele sets, forming 'healthy responder usage formats'. These formats were absent from the pMS patient V-beta gene allele combinations evaluated in this study. Hierarchical clustering of the BV gene combinations, distinguish three pMS auTCL groups, implying existence of up to three disease-related immune response patterns. These subgroup patterns may reflect different disease subclasses or alternatively they may suggest immune reactivity to different aetiological agents. Analyses of clonal-clustering patterns may potentially aid in subclassification of MS or in characterizing aetiological agents of this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740385      PMCID: PMC2767318          DOI: 10.1111/j.1365-2567.2009.03117.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Immunological adjuvants promote activated T cell survival via induction of Bcl-3.

Authors:  T C Mitchell; D Hildeman; R M Kedl; T K Teague; B C Schaefer; J White; Y Zhu; J Kappler; P Marrack
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

Review 2.  Driver clones and determinant spreading.

Authors:  E E Sercarz
Journal:  J Autoimmun       Date:  2000-06       Impact factor: 7.094

Review 3.  Diagnostic criteria for multiple sclerosis.

Authors:  C M Poser; V V Brinar
Journal:  Clin Neurol Neurosurg       Date:  2001-04       Impact factor: 1.876

Review 4.  T cell receptor V genes in multiple sclerosis: increased use of TCRAV8 and TCRBV5 in MBP-specific clones.

Authors:  H Offner; A A Vandenbark
Journal:  Int Rev Immunol       Date:  1999       Impact factor: 5.311

5.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.

Authors:  Christopher Lock; Guy Hermans; Rosetta Pedotti; Andrea Brendolan; Eric Schadt; Hideki Garren; Annette Langer-Gould; Samuel Strober; Barbara Cannella; John Allard; Paul Klonowski; Angela Austin; Nagin Lad; Naftali Kaminski; Stephen J Galli; Jorge R Oksenberg; Cedric S Raine; Renu Heller; Lawrence Steinman
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

6.  Varicella-zoster virus at relapses of multiple sclerosis.

Authors:  Julio Sotelo; Graciela Ordoñez; Benjamin Pineda
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

7.  Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis.

Authors:  M K Sharief; Y K Semra
Journal:  J Neuroimmunol       Date:  2001-10-01       Impact factor: 3.478

8.  Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins.

Authors:  Y K Semra; O A Seidi; M K Sharief
Journal:  J Neuroimmunol       Date:  2002-01       Impact factor: 3.478

9.  Interaction of disease-related antigen-reactive T-cell lines from multiple sclerosis patients with type IV collagen: role of integrin VLA-1 and effects of irradiation.

Authors:  Ilan Bank; Anat Achiron; Gad Levie; Alexander Koltakov; Mathilda Mandel
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.317

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  2 in total

1.  Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.

Authors:  Omri Snir; Mary Rieck; John A Gebe; Betty B Yue; Crystal A Rawlings; Gerald Nepom; Vivianne Malmström; Jane H Buckner
Journal:  Arthritis Rheum       Date:  2011-10

2.  CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.

Authors:  Yonglin Chen; Hui Peng; Yongyan Chen; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.